
What will AI and clinical trials look like in the year 2030? Mike Sullivan, head of IT globally for development operations at Bristol Myers Squibb, joins The Scope of Things to discuss how creating value with AI depends on redesigning how clinical operations teams work. He covers the four pillars of what AI and clinical operations can look like in the next few years, as well as how AI will affect the job market. Plus, host Deborah Borfitz gives you the latest rundown on building the capacity ...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Episode: 54 - Ken Getz and Rick Ward on Why Source Preparation Delays Clinical Trials

Episode: 53 - Daphne Smyth on the Chinese Drug Development Market Expansion

Episode: 52 - Raj Indupuri on Adoption Hurdles with AI Agents

Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr.
Free AI-powered recaps of The Scope of Things and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.